Loading clinical trials...
Loading clinical trials...
A Phase 1b/2 Open Label Study to Evaluate the Safety and Efficacy of TRU-016 in Combination With Bendamustine vs. Bendamustine Alone in Patients With Relapsed Chronic Lymphocytic Leukemia
Conditions
Interventions
TRU-016 and bendamustine
Bendamustine
+2 more
Locations
25
United States
For additional information regarding sites for this trial call (919) 465-4648
Denver, Colorado, United States
For additional information regarding sites for this trial call (919) 465-4648
Augusta, Georgia, United States
For additional information regarding sites for this trial call (919) 465-4648
Chicago, Illinois, United States
For additional information regarding sites for this trial call (919) 465-4648
Hackensack, New Jersey, United States
For additional information regarding sites for this trial call (919) 465-4648
Syracuse, New York, United States
For additional information regarding sites for this trial call (919) 465-4648
Durham, North Carolina, United States
Start Date
September 1, 2010
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
June 10, 2021
NCT07030400
NCT06043011
NCT06528301
NCT03342144
NCT05168930
NCT04758975
Lead Sponsor
Aptevo Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions